ES2506168T3 - Polipéptido que tiene actividad antibacteriana y actividad que induce la angiogénesis y fármacos que contienen dicho polipéptido que curan heridas - Google Patents
Polipéptido que tiene actividad antibacteriana y actividad que induce la angiogénesis y fármacos que contienen dicho polipéptido que curan heridas Download PDFInfo
- Publication number
- ES2506168T3 ES2506168T3 ES10780549.1T ES10780549T ES2506168T3 ES 2506168 T3 ES2506168 T3 ES 2506168T3 ES 10780549 T ES10780549 T ES 10780549T ES 2506168 T3 ES2506168 T3 ES 2506168T3
- Authority
- ES
- Spain
- Prior art keywords
- polypeptide
- activity
- drugs containing
- heal wounds
- induces angiogenesis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Communicable Diseases (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Un polipéptido cuya secuencia de aminoácidos se muestra en una cualquiera de SEQ ID NOs: 8 y 10; en donde el ácido amino 17º en la SEQ ID NO: 8 es D-Lys y el aminoácido 18º en la SEC ID NO: 10 es D-Lys.
Description
31
41
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009125072 | 2009-05-25 | ||
JP2009125072 | 2009-05-25 | ||
PCT/JP2010/058838 WO2010137594A1 (ja) | 2009-05-25 | 2010-05-25 | 血管新生誘導活性及び抗菌活性を有するポリペプチドおよびそれを含有する創傷治療剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2506168T3 true ES2506168T3 (es) | 2014-10-13 |
Family
ID=43222702
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES10780549.1T Active ES2506168T3 (es) | 2009-05-25 | 2010-05-25 | Polipéptido que tiene actividad antibacteriana y actividad que induce la angiogénesis y fármacos que contienen dicho polipéptido que curan heridas |
Country Status (5)
Country | Link |
---|---|
US (2) | US8969311B2 (es) |
EP (1) | EP2436688B1 (es) |
JP (1) | JP5750766B2 (es) |
ES (1) | ES2506168T3 (es) |
WO (1) | WO2010137594A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9376470B2 (en) | 2008-11-28 | 2016-06-28 | Funpep Inc. | Polypeptide having angiogenesis-inducing activity and antibacterial activity, and use thereof for medical purposes |
JP5750765B2 (ja) | 2009-03-06 | 2015-07-22 | 株式会社ファンペップ | ポリペプチド及びその抗菌または消毒用途 |
JP6042106B2 (ja) * | 2011-06-10 | 2016-12-14 | 株式会社ファンペップ | メチオニン・スルホキシドを含む新規ポリペプチド |
JP6319911B2 (ja) * | 2013-03-29 | 2018-05-09 | 国立大学法人大阪大学 | 抗老化作用を有するペプチドおよびその利用 |
US10112978B2 (en) | 2014-09-26 | 2018-10-30 | Osaka University | Peptide and use thereof |
WO2017164409A1 (ja) * | 2016-03-25 | 2017-09-28 | 国立大学法人大阪大学 | 疾患の要因となる生体内タンパク質を標的とするコンジュゲートワクチン |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4939224A (en) | 1987-02-26 | 1990-07-03 | The Salk Institute Biotechnology/Industrial Associates, Inc. | Vasoactive intestinal peptide analogs |
AU7470400A (en) | 1999-08-18 | 2001-03-13 | Regents Of The University Of California, The | Cathelicidin-derived peptides with broad spectrum antimicrobial activity |
WO2005049819A1 (ja) | 2003-10-29 | 2005-06-02 | Toagosei Co., Ltd. | 抗菌ペプチド及びその利用 |
US20050214321A1 (en) | 2003-12-01 | 2005-09-29 | Dow Global Technologies Inc. | Recombinant icosahedral virus like particle production in pseudomonads |
US7807176B2 (en) | 2004-03-19 | 2010-10-05 | Genomidea, Inc. | Polypeptide promoting vascular endothelial cell growth |
US7452856B2 (en) | 2004-07-06 | 2008-11-18 | Seikagaku Corporation | Antibacterial peptide |
SE0402807D0 (sv) | 2004-11-17 | 2004-11-17 | Dermagen Ab | Novel antimicrobial peptides |
US20080025962A1 (en) | 2004-11-30 | 2008-01-31 | Angesmg,Inc. | Remedy for Alzheimer's Disease |
JP4730584B2 (ja) | 2004-12-06 | 2011-07-20 | 東亞合成株式会社 | 抗菌ペプチド及びその利用 |
WO2006132204A1 (ja) | 2005-06-06 | 2006-12-14 | Anges Mg, Inc. | 転写因子デコイ |
JP5134964B2 (ja) | 2005-10-05 | 2013-01-30 | ジェノミディア株式会社 | 単離されたヒト細胞、その取得方法及び用途 |
US20100167390A1 (en) | 2005-12-22 | 2010-07-01 | Toshohiro Nakajima | Novel Oligonucleotide and NF-kB Decoy Comprising the Same |
WO2008096816A1 (ja) * | 2007-02-09 | 2008-08-14 | Genomidea Inc. | 血管新生誘導剤及びそれに用いられるポリペプチド |
JP5384948B2 (ja) * | 2007-02-09 | 2014-01-08 | ジェノミディア株式会社 | 新規ポリペプチド及びそれを有効成分として含有する抗菌剤 |
US9376470B2 (en) * | 2008-11-28 | 2016-06-28 | Funpep Inc. | Polypeptide having angiogenesis-inducing activity and antibacterial activity, and use thereof for medical purposes |
JP5750765B2 (ja) | 2009-03-06 | 2015-07-22 | 株式会社ファンペップ | ポリペプチド及びその抗菌または消毒用途 |
-
2010
- 2010-05-25 EP EP10780549.1A patent/EP2436688B1/en active Active
- 2010-05-25 JP JP2011516026A patent/JP5750766B2/ja active Active
- 2010-05-25 US US13/322,424 patent/US8969311B2/en active Active
- 2010-05-25 ES ES10780549.1T patent/ES2506168T3/es active Active
- 2010-05-25 WO PCT/JP2010/058838 patent/WO2010137594A1/ja active Application Filing
-
2015
- 2015-01-23 US US14/604,567 patent/US9695219B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20150133365A1 (en) | 2015-05-14 |
EP2436688A1 (en) | 2012-04-04 |
JP5750766B2 (ja) | 2015-07-22 |
EP2436688A4 (en) | 2013-01-16 |
US8969311B2 (en) | 2015-03-03 |
EP2436688B1 (en) | 2014-07-09 |
US9695219B2 (en) | 2017-07-04 |
WO2010137594A1 (ja) | 2010-12-02 |
JPWO2010137594A1 (ja) | 2012-11-15 |
US20120172287A1 (en) | 2012-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2506168T3 (es) | Polipéptido que tiene actividad antibacteriana y actividad que induce la angiogénesis y fármacos que contienen dicho polipéptido que curan heridas | |
ES2486675T3 (es) | Análogo de péptido de oxintomodulina | |
ES2512141T3 (es) | Análogo peptídico de oxintomodulina | |
CO6420359A2 (es) | Anticuerpo anti-lectina similar a inmuglobulina de unión a ácido siálico-15 | |
NZ597580A (en) | Polypeptides selective for alpha.v.beta.3 integrin conjugated with a variant of human serum albumin (hsa) and pharmaceutical uses thereof | |
ES2691070T3 (es) | Péptidos antiinflamatorios y composición que comprende los mismos | |
PE20140617A1 (es) | Alfa glucosidasa acida modificada con procesamiento acelerado | |
AR052056A1 (es) | Tratamiento antiangiogenico de enfermedades autoinmunitarias en pacientes que no han respondido a untratamiento previo | |
ES2531083T3 (es) | Formulaciones estables de polipéptidos y usos de las mismas | |
CL2012002356A1 (es) | Compuestos heterociclicos acidos derivados de ariltriazolonas ligadas a bisarilo, inhibidores de receptores de vasopresina v1a y v2; procedimiento de preparacion; composicion farmaceutica; y su uso para tratar y/o prevenir insuficiencia cardiaca aguda y cronica, hiponatremia, entre otras. | |
UA108646C2 (xx) | Клостридіальні токсини, що руйнуються | |
NZ588200A (en) | Procoagulant peptides | |
AR083448A1 (es) | Polipeptidos con actividad quinasa | |
NZ707439A (en) | Modified factor ix polypeptides and uses thereof | |
MX348047B (es) | Proteinas de fusion terapeuticas. | |
PE20160507A1 (es) | Diferenciacion de celulas madre mesenquimales | |
CL2007001488A1 (es) | Anticuerpo humano o humanizado anti-integrina alfa5beta1; acido nucleico que lo codifica; vector y celula huesped que lo comprenden; procedimiento de produccion; composicion farmaceutica que lo comprende; y su uso para prevenir o tratar trastornos asociados con la integrina. | |
PE20150198A1 (es) | Composicion farmaceutica para el tratamiento de la forma pulmonar de mal de montana por falta de oxigeno y presion de aire reducida | |
ES2555557R1 (es) | Fármaco y uso para preparar un medicamento destinado a la prevención de la infección del VIH y al tratamiento de enfermedades causadas por el VIH, incluido el SIDA | |
NZ610620A (en) | Inhibitors of apoptosis and uses thereof | |
NZ602380A (en) | Peptides for vaccine against birch allergy | |
PE20120019A1 (es) | Combinacion de perindopril y n-{[(7s)-3,4-dimetoxibiciclo[4.2.0]octa-1,3,5-trien-7-il]metil}-3-(7,8-dimetoxi-1,2,4,5-tetrahidro-3h-3-benzazepin-3-il)-n-metil-3-oxo-1-propanamina | |
CL2011002893A1 (es) | Peptido derivado del factor viii; composicion que lo comprende; uso para aumentar la tolerancia a factor viii en individuos que padecen o estan en riesgo de padecer hemofilia a o hemofilia adquirida. | |
PE20121553A1 (es) | Uso de una fuente de l3 y/o l5 como vacuna o como diagnostico para una efermedad parasitaria | |
PE20160847A1 (es) | Nuevo compuesto para el tratamiento de hipoglicemia severa |